| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $94.5M | — | +27.5% |
| Cost of Revenue | $4.8M | — | -60.9% |
| R&D Expense | $20.2M | — | +35.1% |
| SG&A Expense | $102.3M | — | +22.9% |
| Operating Income | -$32.8M | — | +9.8% |
| Pre-tax Income | -$37.6M | — | +6.7% |
| Income Tax | $8K | — | -99.1% |
| Net Income | -$37.6M | — | +8.6% |
| EPS (Basic) | -$0.15 | — | +11.8% |
| EPS (Diluted) | -$0.15 | — | +11.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $31.2M | -54.1% | +1.3% |
| Accounts Receivable | $82.8M | +15.3% | +78.3% |
| Inventory | $128.0M | +4.0% | +20.9% |
| Current Assets | $381.9M | -0.1% | +22.1% |
| Total Assets | $504.5M | +0.6% | +23.0% |
| Current Liabilities | $109.6M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$32.2M | — | +16.2% |
| Capital Expenditures | $69K | — | -78.8% |
| Investing Cash Flow | -$10.0M | — | -450.6% |
| Financing Cash Flow | $5.4M | — | +267.2% |
| Free Cash Flow | -$32.3M | — | +16.7% |
| +44.5% |
| Long-term Debt | $203.5M | +0.3% | +34.5% |
| Total Liabilities | $355.9M | +6.3% | +34.5% |
| Stockholders' Equity | $148.6M | -11.0% | +2.0% |